Bjornsti MA - Search Results

1

Inhibition of human neurotropic virus (JCV) DNA replication in glial cells by camptothecin.

Kerr DA, Chang CF, Gordon J, Bjornsti MA, Khalili K. Kerr DA, et al. Among authors: bjornsti ma. Virology. 1993 Oct;196(2):612-8. doi: 10.1006/viro.1993.1517. Virology. 1993. PMID: 8396804

2

SCT1 mutants suppress the camptothecin sensitivity of yeast cells expressing wild-type DNA topoisomerase I.

Kauh EA, Bjornsti MA. Kauh EA, et al. Among authors: bjornsti ma. Proc Natl Acad Sci U S A. 1995 Jul 3;92(14):6299-303. doi: 10.1073/pnas.92.14.6299. Proc Natl Acad Sci U S A. 1995. PMID: 7603986 Free PMC article.

3

Yeast Saccharomyces cerevisiae as a model system to study the cytotoxic activity of the antitumor drug camptothecin.

Bjornsti MA, Knab AM, Benedetti P. Bjornsti MA, et al. Cancer Chemother Pharmacol. 1994;34 Suppl:S1-5. doi: 10.1007/BF00684856. Cancer Chemother Pharmacol. 1994. PMID: 8070016 Review.

4

Increased camptothecin toxicity induced in mammalian cells expressing Saccharomyces cerevisiae DNA topoisomerase I.

Hann C, Evans DL, Fertala J, Benedetti P, Bjornsti MA, Hall DJ. Hann C, et al. Among authors: bjornsti ma. J Biol Chem. 1998 Apr 3;273(14):8425-33. doi: 10.1074/jbc.273.14.8425. J Biol Chem. 1998. PMID: 9525954 Free article.

5

A camptothecin-resistant DNA topoisomerase I mutant exhibits altered sensitivities to other DNA topoisomerase poisons.

Knab AM, Fertala J, Bjornsti MA. Knab AM, et al. Among authors: bjornsti ma. J Biol Chem. 1995 Mar 17;270(11):6141-8. doi: 10.1074/jbc.270.11.6141. J Biol Chem. 1995. PMID: 7890748 Free article.

6

Mechanisms of camptothecin resistance in yeast DNA topoisomerase I mutants.

Knab AM, Fertala J, Bjornsti MA. Knab AM, et al. Among authors: bjornsti ma. J Biol Chem. 1993 Oct 25;268(30):22322-30. J Biol Chem. 1993. PMID: 8226741 Free article.

7

Camptothecin sensitivity is mediated by the pleiotropic drug resistance network in yeast.

Reid RJ, Kauh EA, Bjornsti MA. Reid RJ, et al. Among authors: bjornsti ma. J Biol Chem. 1997 May 2;272(18):12091-9. doi: 10.1074/jbc.272.18.12091. J Biol Chem. 1997. PMID: 9115278 Free article.

8

CDC45 and DPB11 are required for processive DNA replication and resistance to DNA topoisomerase I-mediated DNA damage.

Reid RJ, Fiorani P, Sugawara M, Bjornsti MA. Reid RJ, et al. Among authors: bjornsti ma. Proc Natl Acad Sci U S A. 1999 Sep 28;96(20):11440-5. doi: 10.1073/pnas.96.20.11440. Proc Natl Acad Sci U S A. 1999. PMID: 10500195 Free PMC article.

9

Substitutions of Asn-726 in the active site of yeast DNA topoisomerase I define novel mechanisms of stabilizing the covalent enzyme-DNA intermediate.

Fertala J, Vance JR, Pourquier P, Pommier Y, Bjornsti MA. Fertala J, et al. Among authors: bjornsti ma. J Biol Chem. 2000 May 19;275(20):15246-53. doi: 10.1074/jbc.275.20.15246. J Biol Chem. 2000. PMID: 10809761 Free article.

10

Expression of human DNA topoisomerase I in yeast cells lacking yeast DNA topoisomerase I: restoration of sensitivity of the cells to the antitumor drug camptothecin.

Bjornsti MA, Benedetti P, Viglianti GA, Wang JC. Bjornsti MA, et al. Cancer Res. 1989 Nov 15;49(22):6318-23. Cancer Res. 1989. PMID: 2553253

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73 results

Search Page

Filters